Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease

European Heart Journal

Volumn 34, Issue 23, 2013, Pages 1732-1739

  Johansen, Christine D ^a   Olsen, Rasmus H ^a   Pedersen, Lene R ^a   Kumarathurai, Preman ^a   Mouridsen, Mette R ^a   Binici, Zeynep ^b   Intzilakis, Theodoros ^c   Køber, Lars ^d   Sajadieh, Ahmad ^a,c  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

24 h heart rate; Mortality; Night time heart rate; Prognosis; Resting heart rate

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NIGHT TIME HEART RATE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REST; RESTING HEART RATE; REVASCULARIZATION; RR INTERVAL; SENESCENCE; SEX; SMOKING; SYSTOLIC BLOOD PRESSURE;

24 H HEART RATE; MORTALITY; NIGHT-TIME HEART RATE; PROGNOSIS; RESTING HEART RATE;

AGED; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; EPIDEMIOLOGIC METHODS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; REST;

EID: 84879097664     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs449     Document Type: Article

References (32)

1. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1991;121:172-177.
2. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-749.
3. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494.
4. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-830.
5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-2414.
6. Ceconi C, Guardigli G, Rizzo P, Francolini G, Ferrari R. The heart rate story. Eur Heart J Suppl 2011;13:C4-C13.
7. Verrier RL, Tan A. Heart rate, autonomic markers, and cardiac mortality. Heart Rhythm 2009;6:S68-S75.
8. Palatini P. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs 2007;67:3-13.
9. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003;56:124-130.
10. WMA Declaration of Helsinki. Ethical principles for medical research involving human subjects. http://www.wma.net/en/30publications/10policies/b3/ index.html (8 June 2012).
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;28:499-511.
12. Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010;159:612-619.
13. Aronow WS, Ahn C, Mercando AD, Epstein S. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996;78:1175-1176.
14. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999;159:585-592.
15. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, de Leeuw PW, Jaaskivi M, Leonetti G, Nachev C, O'Brien ET, Parati G, Rodicio JL, Roman E, Sarti C, Tuomilehto J; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162:2313-2321.
16. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-370.
17. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary artery atherosclerosis. J Cardiovasc Pharmacol 1987;10:S100-S102; discussion S103.
18. Ku DN, Giddens DP. Pulsatile flow in a model carotid bifurcation. Arteriosclerosis 1983;3:31-39.
19. Beere PA, Glagov S, Zarins CK. Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Localization, compensatory enlargement, and the sparing effect of lowered heart rate. Arterioscler Thromb 1992;12:1245-1253.
20. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart ratedependence of arterial distensibility in vivo. J Hypertens 1996;14:897-901.
21. Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997;11:S19-S27.
22. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J (eds), Cardiac Electrophysiology: From Cell to Bedside. 1st ed. Philadelphia: WB Saunders Co; 1990, p330-343.
23. Kjekshus J. Comments-beta-blockers: heart rate reduction a mechanism of benefit. Eur Heart J 1985;6:29-30.
24. Gundersen T, Grøttum P, Pedersen T, Kjekshus JK. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 1986;58:20-24.
25. Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:807-816.
26. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010;376:875-885.
27. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008;372:817-821.
28. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010;376:886-894.
29. Aydin M, Altin R, Ozeren A, Kart L, Bilge M, Unalacak M. Cardiac autonomic activity in obstructive sleep apnea: time-dependent and spectral analysis of heart rate variability using 24-hour Holter electrocardiograms. Tex Heart Inst J 2004; 31:132-136.
30. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010;90:47-112.
31. Zhu K, Chemla D, Roisman G, Mao W, Bazizi S, Lefevre A, Escourrou P. Overnight heart rate variability in patients with obstructive sleep apnoea: a timeand frequency-domain study. Clin Exp Pharmacol Physiol 2012;39:901-908.
32. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997; 30:1104-1106.